STEPHENS INVESTMENT MANAGEMENT GROUP LLC – Halozyme Therapeutics, Inc. Transaction History
STEPHENS INVESTMENT MANAGEMENT GROUP LLC portfolio value:
$51.36M
portfolio value
STEPHENS INVESTMENT MANAGEMENT GROUP LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.39% | -5.04K shares | -6.01M | $39.54 | 1.29M |
| Q2 2022 | share | Increase | +0.70% | 9.04K shares | 5.73M | $44 | 1.30M |
| Q1 2022 | share | Increase | +1.59% | 20.25K shares | 387K | $39.88 | 1.29M |
| Q4 2021 | share | Increase | +0.33% | 4.19K shares | -428K | $40.32 | 1.27M |
| Q3 2021 | share | Increase | +15.73% | 172.72K shares | 1.83M | $40.68 | 1.27M |
| Q2 2021 | share | Increase | +0.39% | 4.21K shares | 4.25M | $45.41 | 1.09M |
| Q1 2021 | share | Increase | +12.25% | 119.33K shares | 3.98M | $41.69 | 1.09M |
| Q4 2020 | share | Increase | +262.30% | 705.30K shares | 34.54M | $42.71 | 974.20K |
| Q3 2020 | share | Increase | +54.30% | 94.62K shares | 2.39M | $26.28 | 268.89K |
| Q2 2020 | share | Increase | 0.00% | 174.27K shares | 4.67M | $26.81 | 174.27K |